PARPs
Open accessAbstract
Leung introduces the various roles of PARPs and the regulation of ADP-ribosylation of protein substrates.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Among 17 PARPs, only PARP1, PARP2, PARP5a, and PARP5b can add multiple ADP-ribose units (PARylation).
“Among the 17 PARPs, only four of them are capable of adding multiple ADP-ribose units (poly[ADP-ribosyl]ation) or PARylation; they are PARP1, PARP2, PARP5a (tankyrase 1), and PARP5b (tankyrase 2) (Leung, 2017; Rouleau et al., 2010).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Leung, 2017
Cites
PARP inhibitors: Synthetic lethality in the clinic
Lord, C. J., & Ashworth, A. (2017) · Science · doi:10.1126/science.aam7344 · Cited by 2,932 · see citing works
Toward a unified nomenclature for mammalian ADP-ribosyltransferases
Hottiger, M. O., Hassa, P. O., Lüscher, B., Schuler, H., & Koch‐Nolte, F. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.12.003 · Cited by 814 · see citing works
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · see citing works
Family-wide analysis of poly(ADP-ribose) polymerase activity
Vyas, S., Matić, I., Uchima, L., Rood, J., Žaja, R., Hay, R. T., Ahel, I., & Chang, P. (2014) · Nature Communications · doi:10.1038/ncomms5426 · Cited by 503 · see citing works
Biosensor reveals multiple sources for mitochondrial NAD <sup>+</sup>
Cambronne, X. A., Stewart, M. L., Kim, D., Jones-Brunette, A. M., Morgan, R. K., Farrens, D. L., Cohen, M. S., & Goodman, R. H. (2016) · Science · doi:10.1126/science.aad5168 · Cited by 407 · see citing works
Thorsell, A. G., Ekblad, T., Karlberg, T., Löw, M., Pinto, A. F., Tresaugues, L., Moche, M., Cohen, M. S., & Schuler, H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00990 · Cited by 369 · see citing works
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Berger, N. A., Besson, V. C., Boulares, A. H., Bürkle, A., Chiarugi, A., Clark, R. S. B., Curtin, N. J., Cuzzocrea, S., Dawson, T. M., Dawson, V. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13748 · Cited by 212 · see citing works
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9
Yang, C., Jividen, K., Spencer, A., Dworak, N. M., Li, N., Oostdyk, L. T., Chatterjee, M., Kuśmider, B., Reon, B. J., Parlak, M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.028 · Cited by 205 · see citing works
The Promise of Proteomics for the Study of ADP-Ribosylation
Daniels, C. M., Ong, S., & Leung, A. K. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.012 · Cited by 196 · see citing works
Self-citationRapid Evolution of PARP Genes Suggests a Broad Role for ADP-Ribosylation in Host-Virus Conflicts
Daugherty, M. D., Young, J. M., Kerns, J. A., & Malik, H. S. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004403 · Cited by 176 · see citing works
Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation
Feijs, K. L. H., Forst, A. H., Verheugd, P., & Lüscher, B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3601 · Cited by 154 · see citing works
ADP ‐ribosylation: new facets of an ancient modification
Palazzo, L., Mikoč, A., & Ahel, I. (2017) · FEBS Journal · doi:10.1111/febs.14078 · Cited by 145 · see citing works
The recognition and removal of cellular poly( ADP ‐ribose) signals
Barkauskaite, E., Jankevicius, G., Ladurner, A. G., Ahel, I., & Timinszky, G. (2013) · FEBS Journal · doi:10.1111/febs.12358 · Cited by 124 · see citing works
ADPriboDB: The database of ADP-ribosylated proteins
Vivelo, C. A., Wat, R., Agrawal, C., Tee, H. Y., & Leung, A. K. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw706 · Cited by 67 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
NAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790 · see citing works
Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5
Hrubša, M., Siatka, T., Najmanová, I., Vopršalová, M., Krčmová, L. K., Matoušová, K., Javorská, L., Macáková, K., Mercolini, L., Remião, F., et al. (2022) · Nutrients · doi:10.3390/nu14030484 · Cited by 277 · see citing works
NAD+ homeostasis in human health and disease
Perez, R. Z., Wanders, R. J. A., van Karnebeek, C., & Houtkooper, R. H. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202113943 · Cited by 238 · see citing works
Buch-Larsen, S. C., Hendriks, I. A., Lyon, D. B., Jensen, L. J., & Nielsen, M. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.083 · Cited by 179 · see citing works
Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation
O’Sullivan, J. A., Ferreira, M. T., Gagné, J., Sharma, A. K., Hendzel, M. J., Masson, J., & Poirier, G. G. (2019) · Nature Communications · doi:10.1038/s41467-019-08859-x · Cited by 161 · see citing works
Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation
Leung, A. K. L. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.002 · Cited by 153 · see citing works
Self-citationKim, D.-S., Challa, S., Jones, A., & Kraus, W. L. (2020) · Genes & Development · doi:10.1101/gad.334433.119 · Cited by 143 · see citing works
Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Reiten, O. K., Wilvang, M. A., Mitchell, S. J., Hu, Z., & Fang, E. F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111567 · Cited by 133 · see citing works
Millar, S. R., Huang, J. Q., Schreiber, K. J., Tsai, Y.-C., Won, J., Zhang, J., Moses, A. M., & Youn, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00608 · Cited by 120 · see citing works
Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation
Hopp, A.-K., Grüter, P., & Hottiger, M. O. (2019) · Cells · doi:10.3390/cells8080890 · Cited by 107 · see citing works
The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome
Hendriks, I. A., Buch-Larsen, S. C., Prokhorova, E. A., Elsborg, J. D., Rebak, A. K. L. F. S., Zhu, K., Ahel, D., Lukas, C., Ahel, I., & Nielsen, M. L. (2021) · Nature Communications · doi:10.1038/s41467-021-26172-4 · Cited by 97 · see citing works
Fu, H., Liu, R., Jia, Z., Li, R., Zhu, F., Zhu, W., Shao, Y., Jin, Y., Xue, Y., Huang, J., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00872-5 · Cited by 83 · see citing works
Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice
Perez, R. Z., Tammaro, A., Schomakers, B. V., Scantlebery, A. M. L., Denis, S. W., Elfrink, H. L., Giroud‐Gerbetant, J., Cantó, C., López‐Leonardo, C., McIntyre, R. L., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001826r · Cited by 75 · see citing works
Aberle, L., Krüger, A., Reber, J. M., Lippmann, M., Hufnagel, M., Schmalz, M. F., Trussina, I. R. E. A., Schlesiger, S., Zubel, T., Schütz, K., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa590 · Cited by 72 · see citing works
The therapeutic perspective of NAD+ precursors in age-related diseases
Iqbal, T., & Nakagawa, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149590 · Cited by 65 · see citing works
Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52 · see citing works
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation
Lu, A. Z., Abo, R., Ren, Y., Gui, B., Mo, J.-R., Blackwell, D. J., Wigle, T. J., Keilhack, H., & Niepel, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.007 · Cited by 50 · see citing works
Roles of NAD+ in Acute and Chronic Kidney Diseases
Morevati, M., Fang, E. F., Mace, M. L., Kanbay, M., Gravesen, E., Nordholm, A., Egstrand, S., & Hornum, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010137 · Cited by 49 · see citing works
Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
Maggiore, A., Casale, A. M., Toscanelli, W., Cappucci, U., Rotili, D., Grieco, M., Gagné, J.-P., Poirier, G. G., d’Erme, M., & Piacentini, L. (2022) · Cells · doi:10.3390/cells11081284 · Cited by 40 · see citing works
NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging
Wagner, S., Manickam, R., Brotto, M. A. P., & Tipparaju, S. M. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04408-1 · Cited by 39 · see citing works
Veith, S., Schink, A., Engbrecht, M., Mack, M., Rank, L., Rossatti, P., Hakobyan, M., Goly, D., Hefele, T., Frensch, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46358-7 · Cited by 36 · see citing works
Carollo, C., Sorce, A., Cirafici, E., Mulè, G., & Caimi, G. (2025) · Nutrients · doi:10.3390/nu17071212 · Cited by 27 · see citing works
Temporal and Site-Specific ADP-Ribosylation Dynamics upon Different Genotoxic Stresses
Buch-Larsen, S. C., Rebak, A. K. L. F. S., Hendriks, I. A., & Nielsen, M. L. (2021) · Cells · doi:10.3390/cells10112927 · Cited by 24 · see citing works
Influence of chain length and branching on poly(ADP-ribose)–protein interactions
Löffler, T., Krüger, A., Zirak, P., Winterhalder, M., Müller, A.-L., Fischbach, A., Mangerich, A., & Zumbusch, A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1235 · Cited by 23 · see citing works
Bashyal, A., & Brodbelt, J. S. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21811 · Cited by 22 · see citing works
Functional Roles of Poly(ADP-Ribose) in Stress Granule Formation and Dynamics
Jin, X., Cao, X., Liu, S., & Liu, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.671780 · Cited by 17 · see citing works
Thirawatananond, P., McPherson, R. L., Malhi, J. K., Nathan, S., Lambrecht, M. J., Brichacek, M. P., Hergenrother, P. J., Leung, A. K. L., & Gabelli, S. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-39491-w · Cited by 16 · see citing works
Self-citationVainonen, J. P., Gossens, R., Krasensky-Wrzaczek, J., Masi, R. D., Danciu, I., Puukko, T., Battchikova, N., Jonak, C., Wirthmueller, L., Wrzaczek, M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04794-2 · Cited by 15 · see citing works
Beneyton, A., Nonfoux, L., Gagné, J., Rodrigue, A., Kothari, C., Atalay, N., Hendzel, M. J., Poirier, G. G., & Masson, J. (2023) · NAR Cancer · doi:10.1093/narcan/zcad043 · Cited by 13 · see citing works
Fu, X., Zhang, J., Sun, K., Zhang, M., Wang, S., Yuan, M., Liu, W., Zeng, X., Ba, X., & Ke, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05292-2 · Cited by 12 · see citing works
Targeting selective inhibitors of PARPs in drug discovery and development
Duan, M., Gao, J., Li, J., Huang, X., Ren, Y., Li, Y., Liao, M., & Zhang, Y. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03282-4 · Cited by 9 · see citing works
Assay technologies facilitating drug discovery for ADP‐ribosyl writers, readers and erasers
Glumoff, T., Sowa, S. T., & Lehtiö, L. (2021) · BioEssays · doi:10.1002/bies.202100240 · Cited by 9 · see citing works
Vainonen, J. P., Shapiguzov, A., Krasensky-Wrzaczek, J., Gossens, R., Masi, R. D., Danciu, I., Puukko, T., Battchikova, N., Jonak, C., Wirthmueller, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.02.184937 · Cited by 9 · see citing works
PARP12 regulates mouse oocyte meiotic maturation
Cao, G., Guo, R., Chen, M., Sun, C., & Wang, J. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31037 · Cited by 8 · see citing works
Rizvi, A., Merlin, M. A., & Shah, G. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174546 · Cited by 8 · see citing works
Bianchi, A. R., Capua, I. D., Guerretti, V., Guagliardi, A., Carotenuto, Y., & Maio, A. D. (2024) · Euro-Mediterranean Journal for Environmental Integration · doi:10.1007/s41207-024-00625-w · Cited by 3 · see citing works
Decoding PARP roles in breast cancer therapy resistance
Abohassan, M., Altalbawy, F. M. A., Jabir, M. S., Hasan, T. F., Kyada, A., Nathiya, D., Kaur, P., Kumar, M. R., Abosaoda, M. K., & Iqbal, M. S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12223-w · Cited by 2 · see citing works
Si-zeng, C. H. E. N., & Zheng, L. (2021) · Biomedical Research · doi:10.2220/biomedres.42.247 · Cited by 2 · see citing works
Pan, B.-Z., Luo, Q.-Y., Jiang, M., Ning, D., Deng, L., Dai, X., Wu, Z., Deng, Z., Luo, D.-Y., Wang, Y.-Y.-J., et al. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02239-9 · Cited by 1 · see citing works
Nicotinamide Adenine Dinucleotide and Signaling Transduction
Xu, H., Zhang, D., Sun, M., & Qin, Z.-H. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_17
Cunningham, M. L., Vasquez‐Gonzalez, J., Barnada, S. M., Tchotorlishvili, S., Jones, L., Maguire, R., Lewis, G., Rizwan, K., Deng, J., Koachar, S., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70098
Regulation of chromatin structure and function by adenosine diphosphate (ADP)-ribosylation
Huang, D., Edwards, A. D., & Kraus, W. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00007-6
Structural and evolutionary insights into chicken ADP-ribosyl transferases (ARTs)
Bandi, J. P., Rohaim, M. A., Atasoy, M. O., Naggar, R. F. E., Copeland, N. A., & Munir, M. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102672
- Authors
- Leung, A. K. L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Leung, Anthony K.L.
- ORCID
- Leung, Anthony K.L.
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 27
- Issue
- 23
- Pages
- R1256-R1258
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W4247349884
- Cited by
- 44
- References
- 14
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 7 · 2018: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Current Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM104135)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- poly(ADP-ribose) polymerase, ADP-ribosylation, protein substrates, post-translational modification, DNA damage response
- MeSH terms
- Poly(ADP-ribose) Polymerases, Eukaryota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review